Versartis Inc.

(VSAR) Trade

By |

Profile

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

Contact Information

Website: www.versartis.com
Email: IR@versartis.com
Main Phone: +1 650 963-8580
Address: 1020 Marsh Road
Address 2: Suite 250
State: CA
City / Town: Menlo Park
Country: USA
Postal Code: 94025

Issuer Information

Exchange: NGS
CEO: Jay P. Shepard
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 2.40 $ 0. (0.00%)
Last Price 2.40 Change $ 0. Change % 0.00 Tick N/A
Bid 1.70 Bid Size 2,000.00 Ask 2.75 Ask Size 600.00
Open 2.30 High 2.45 Low 2.25 Prev Close 2.40
Last Trade Volume 667,366 52 Wk Hi 22.10 52 Wk Low 1.35
Market Cap 86.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 36,081,466.00 EPS (TTM) -1.81 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 6 47
Number of Buys 3 29
Number of Sells 3 18
Net Activity 1037054 1323208
Last 10 Buys Shares
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Edelman Joseph 1,000
Edelman Joseph 1,000
Edelman Joseph 1,000
Last 10 Sell Shares
Jay P. Shepard 1,000
Jay S. Stout 1,000
Tracy M. Woody 1,000
Kevin Haas 1,000
Shane M. Ward 1,000
Jay P. Shepard 1,000
Paul Westberg 1,000
Paul Westberg 1,000
Shane M. Ward 1,000
Colin Hislop 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3.75 3.75 3.75 3.75
Standard Deviation 0.96 0.96 0.96 0.96
Date of Most Recent Estimate 03/02/18 03/02/18 03/02/18 03/02/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3